Tested Applications
| Positive WB detected in | human testis tissue, A549 cells, PC-3 cells |
| Positive IP detected in | PC-3 cells |
| Positive IHC detected in | human testis tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
| Positive IF/ICC detected in | PC-3 cells |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:200-1:1000 |
| Immunoprecipitation (IP) | IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate |
| Immunohistochemistry (IHC) | IHC : 1:20-1:200 |
| Immunofluorescence (IF)/ICC | IF/ICC : 1:20-1:200 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
20027-1-AP targets DLEC1 in WB, IHC, IF/ICC, IP, ELISA applications and shows reactivity with human, mouse samples.
| Tested Reactivity | human, mouse |
| Cited Reactivity | human |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
Peptide Predict reactive species |
| Full Name | deleted in lung and esophageal cancer 1 |
| Calculated Molecular Weight | 196 kDa |
| Observed Molecular Weight | 80-90 kDa, 46 kDa |
| GenBank Accession Number | NM_007335 |
| Gene Symbol | DLEC1 |
| Gene ID (NCBI) | 9940 |
| RRID | AB_10664924 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | Q9Y238 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Background Information
DLEC1, also named as DLC1 F56, may act as a tumor suppressor by inhibiting cell proliferation.
Protocols
| Product Specific Protocols | |
|---|---|
| IF protocol for DLEC1 antibody 20027-1-AP | Download protocol |
| IHC protocol for DLEC1 antibody 20027-1-AP | Download protocol |
| IP protocol for DLEC1 antibody 20027-1-AP | Download protocol |
| WB protocol for DLEC1 antibody 20027-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
The DLEC1 Polyclonal antibody (Cat# 20027-1-AP) has 2 citations. One appears in Human Genetics, investigating epigenetic silencing of DLEC1 in relation to the tumor immune microenvironment and immunotherapy prognosis across multiple cancers (WB, IHC). The other is in Cancer Medicine, examining a multicellular ecosystem involved in young breast cancer progression through integrated spatial and bulk transcriptomic analysis. The associated research fields span epigenetics, tumor immunology, and breast cancer biology.
| Species | Application | Title |
|---|---|---|
Hum Genet Epigenetic silencing of DLEC1 correlates with tumor immune microenvironment and predicts immunotherapy prognosis in multiple cancers. | ||
Cancer Med Integrated Spatial and Bulk Transcriptomic Analysis Identifies a Multicellular Ecosystem Involved in Progression of Young Breast Cancer. |













